Skip to main content

Cowen Healthcare Investments Successfully Raises $493 Million For Third Fund

Written by Customer Service on . Posted in Public Companies.

NEW YORK, May 19, 2020 (GLOBE NEWSWIRE) — Cowen Healthcare Investments (“CHI”), a private healthcare investment strategy within the investment management division of Cowen Inc. (NASDAQ:COWN), announced today that it has successfully completed fundraising for Cowen Healthcare Investments III LP (“CHI III” or the “Fund”) with $493 million, $93 million above the Fund’s original target. CHI received commitments from existing and new investors, including institutional investors, family offices, and high net worth individuals.
Led by Kevin Raidy, Tim Anderson, and Robert Sine, CHI was founded in 2012 to support innovation in the healthcare sector, with a particular focus on biopharma, diagnostics and digital health. CHI focuses its investment activity on established companies with outstanding management teams and disruptive approaches to disease that address significant unfulfilled medical needs. Since 2012 the team has invested in 38 private healthcare companies. Pedro Alvarez-Urena, Ph.D. and Eric Pham, Ph.D. have joined the team over the past two years. Kevin Raidy, Managing Partner, CHI, said, “Investing in premier life sciences companies could not be more critical than it is today. We are extremely optimistic about the prospects of this industry to address urgent, unmet medical needs, and in doing so to transform the lives of patients and their families. We feel privileged to be able to partner with exceptional management teams and like-minded investors to help build the next generation of world-class, innovative healthcare companies.”Elizabeth Flisser Rosman, Cowen Managing Director and Head of Investment Management, added, “As part of Cowen’s DNA, Cowen Healthcare Investments demonstrates our organization’s ability to identify, develop, and deliver differentiated investment strategies. Using Cowen’s powerful platform, we look forward to developing additional investment products that meet our clients’ needs and create long-term value for all of Cowen’s stakeholders.”About CHI:Cowen Healthcare Investments is an investment manager affiliated with Cowen Inc. Cowen Healthcare Investments manages a series of investment funds focused on investing in private healthcare companies across the biopharma, diagnostics and digital health sectors. Founded in 2012, the firm is headquartered in New York. Learn more at www.cowen.com.About Cowen Inc.Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at www.cowen.com.For further information, contact:Gagnier Communications
Dan Gagnier
(646) 569-5897
dg@gagnierfc.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.